Myopia is the most prevalent ocular disorder globally. It is on the rise and reaching epidemic proportions, and Singapore has the dubious reputation of having the highest prevalence in the world. The Singapore Cohort Study of the Risk Factors of Myopia (SCORM) states that the prevalence of myopia (defined as less than 50 degrees) in Singapore children was 27.8% at 7 years old, 34.5% at 8 years old and 43.4% at 9 years old. It is particularly serious in local children with its severity rising almost every year. The degree of myopia increases by more than 150 degrees per year in 9 year-olds on average.

Myopia usually develops and progresses in childhood, but stabilises when one enters adulthood. Our preventive efforts are therefore focused on children. Based on a study by the Singapore Eye Research Institute, Eagle Myopia Control Program has been developed to reduce the progression of myopia in children using atropine eye drops. The study showed a highly promising result with an 80% reduction in myopia progression over 2 years span, proving that myopia progression can be retarded pharmacologically. Importantly, safety data from the study confirmed that atropine eye drops is well tolerated and free from significant complications.

We are proud to announce that 100% of the children, who have since been enrolled in the Eagle Myopia Control Program, have experienced no increase in myopia. With our observations, we are confident that the Eagle Myopia Control Program will be able to maintain its statistics of 100% controlled vision in children even in the years to come.

Download Brochure Now!